FIELD: medicine, combustiology.
SUBSTANCE: invention can be used to predict acute respiratory failure (ARF) in patients with inhalation injury and airway burns on the first day of admission to a hospital. The levels of leukocytosis, C-reactive protein and procalcitonin in venous blood are determined. When receiving leukocytes from 10.7×10*9/l and above, the level of C-reactive protein from 37.7 mg/l and above, the level of procalcitonin from 0.4 ng/ml and above, a high risk of developing ARF in patients corresponding to 75% or more is predicted.
EFFECT: possibility of obtaining more accurate and objective data in predicting the development of ARF in patients with inhalation injury from the first hours of admission to the hospital by determining the number of leukocytes, levels of C-reactive protein and procalcitonin in venous blood.
3 tbl, 3 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR PREDICTION OF FAVORABLE OUTCOME IN PATIENTS WITH THERMAL INJURY FOR CHOOSING THERAPEUTIC APPROACH (VERSIONS) | 2023 |
|
RU2825062C1 |
| METHOD FOR PREDICTION OF RISK OF VENOUS THROMBOEMBOLIC COMPLICATIONS IN SEVERE BURN INJURY | 2020 |
|
RU2737277C1 |
| METHOD FOR PREDICTION OF THE BURN DISEASE OUTCOME IN THE PATIENTS WITH SEVERE THERMAL TRAUMA | 2020 |
|
RU2738303C1 |
| METHOD OF PREDICTING OUTCOME OF BURNING INJURY | 2008 |
|
RU2368320C1 |
| METHOD OF ESTIMATING SEVERITY DEGREE AND PREDICTION OF LETHAL OUTCOME IN PATIENTS WITH COMBINED TRAUMA AND CONTINUED BLEEDING | 2013 |
|
RU2549531C1 |
| METHOD FOR PREDICTION OF OUTCOME OF VIRAL PNEUMONIA IN COVID-19 | 2021 |
|
RU2764002C1 |
| METHOD FOR PREDICTING THE OUTCOME OF VIRAL PNEUMONIA IN COVID-19 | 2021 |
|
RU2766352C1 |
| DEVICE FOR RECANALIZATION OF TRACHEAL AND BRONCHAL STENOSIS | 2021 |
|
RU2770280C1 |
| METHOD FOR PREDICTION OF THROMBOSIS AND BLEEDING IN CRITICAL PATIENTS WITH COVID-19 UNDER CONDITIONS OF ECMO | 2021 |
|
RU2766350C1 |
| AUTOINTOXICATION SEVERITY ESTIMATION PROCEDURE | 2007 |
|
RU2357248C1 |
